Cargando…
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
A recent randomized study of whipworm Trichuris suis ova (TSO) in ileal Crohn’s disease failed to demonstrate a clinical benefit compared to placebo after 12 weeks. Nonetheless, it has recently been shown that the spontaneous small intestinal inflammatory changes in Nod2(-/-) (Nucleotide-binding oli...
Autores principales: | Jaeger, Simon U., Schaeffeler, Elke, Winter, Stefan, Tremmel, Roman, Schölmerich, Jürgen, Malek, Nisar, Stange, Eduard F., Schwab, Matthias, Wehkamp, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054957/ https://www.ncbi.nlm.nih.gov/pubmed/30061834 http://dx.doi.org/10.3389/fphar.2018.00764 |
Ejemplares similares
-
A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn’s Disease
por: Schölmerich, Jürgen, et al.
Publicado: (2017) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
por: Yordanova, Ivet A., et al.
Publicado: (2021) -
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
por: Rosche, Berit, et al.
Publicado: (2013) -
Bacteria-induced egg hatching differs for Trichuris muris and Trichuris suis
por: Vejzagić, Nermina, et al.
Publicado: (2015)